Portfolio Co Investors 2026 for Pivotal Life Sciences: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Pivotal Life Sciences accounts for 4 tracked companies with verified cap-table data, 4 of which disclose round sizes totalling $757M. The median disclosed raise is $100M, and the largest is Gracell Biotechnologies at $520M, ahead of Addition Therapeutics ($100M) and DermBiont ($73M).
The names that recur most often on these co-invested cap tables are Pivotal Life Sciences (4 companies), AstraZeneca (1 company), Vivo Capital (1 company), Temasek (1 company), OrbiMed (1 company), RA Capital Management (1 company). By latest disclosed round, the market skews Series B (2), IPO (1).